Bottom line
Is TLVAX a good fund? The bottom line
TLVAX is a share class of Timothy Plan Large/Mid Cap Value Fund, a managed mid-cap mutual fund from Timothy Plan.
It charges 1.41% — about $141 a year on every $10,000 invested, more expensive than 85% of mid-cap funds we track.
It returned −1.0% over one year, +7.0% a year over five years, +8.8% a year over ten (as of Dec 31, 2025, per its prospectus).
With $324 million in net assets and 42 holdings, its largest position is Timothy Plan (the) (11.2%) and the top 10 make up 41.9% of the portfolio.
This share class carries a front-end sales charge of up to 5.5%; a no-load class or ETF alternative can avoid it.
What to watch
- Expensive for its category (1.41%)
- Front-end sales load up to 5.5%
- 12b-1 marketing fee of 0.25% a year
Updated Nov 19, 2026
What TLVAX invests in
The investment objective of this Fund is to provide you with long-term growth of capital,
? The Fund seeks to achieve its investment objective by primarily investing in U.S. common stocks and affiliated exchange-traded funds (ETFs). The Fund will normally invest at least 80% of the Funds total assets in ETFs and in companies whose total market capitalization exceeds $2 billion. This Fund invests using a value investing style, including value style ETFs. Value funds typically emphasize stocks whose prices are below average in relation to such measures as earnings and book value; these stocks often have above-average dividend yields. Growth and value stocks have historically produced similar long-term returns, though each category has periods when it outperforms the other. ? In determining the allocation between the ETFs and the sub-advised portfolio, among other things, the Adviser, in consultation with an outside market strategy group, considers the short term versus a…
From the fund's prospectus (filed May 5, 2026).
TLVAX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| TLVAX | −1.0% | +7.0% | +8.8% |
| Mid-Cap median | +7.9% | +8.1% | +9.9% |
Source: Fund prospectus, as of Dec 31, 2025
What TLVAX costs
On a $10,000 investment, TLVAX's 1.41% expense ratio costs about $141 a year. The prospectus estimates $2,302 in total costs over 10 years (assuming 5% annual returns). The median mid-cap fund charges 0.88%.
TLVAX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Timothy Plan (the) | 11.21% |
| 2 | Timothy Plan (the) | 9.12% |
| 3 | Fidelity Colchester Street Trust | 4.52% |
| 4 | Hubbell Inc | 2.82% |
| 5 | Qnity Electronics Inc | 2.68% |
| 6 | Littelfuse Inc | 2.52% |
| 7 | Deere & Company | 2.41% |
| 8 | Eog Resources Inc | 2.24% |
| 9 | Nextera Energy Inc | 2.21% |
| 10 | Cullen/frost Bankers Inc | 2.20% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 41.9% of the fund. See all top 25 holdings and asset mix →